Anika Therapeutics Inc. · NASDAQ:ANIK
Anika Therapeutics — Q4 2015 Earnings Presentation
7 slides from Anika Therapeutics's earnings presentation, Feb 25, 2016
Slide 1: Anika Therapeutics Fourth Quarter 2015 Earnings Call Presentation
ANIKA THERAPEUTICS, INC. Fourth Quarter 2015 Earnings Call Presentation February 25, 2016
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT The statements made in this presentation that are not statements of historical fact are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward- looking statements involve known a
Slide 3: Pillars of Growth for Anika
PILLARS OF GROWTH FOR ANIKA Expanding Advancing Globally Pipeline Strategic Strengthening M&A Infrastructure 3
Slide 4: Geographic Expansion and Pipeline Advancement
GEOGRAPHIC EXPANSION AND PIPELINE ADVANCEMENT Commercial Availability in 55+ Countries and Counting • Recently Signed New Commercial Partner in China • Pursuing New Markets including Japan, World’s Second Largest Visco- supplementation Market Pipeline Based on Proprietary HA Technology Platform • CI
Slide 5: Strengthening Infrastructure and Strategic M&A
STRENGTHENING INFRASTRUCTURE AND STRATEGIC M&A Enhancing Company Foundations • Integrating Manufacturing Operations to Accelerate R&D • Developing Direct Commercial Capability to Support Future Products and Optimize Financial Returns Committing to M&A to Complement Existing Business • Renewed Intere
Slide 6: Strong Financial Foundation
STRONG FINANCIAL FOUNDATION Q4 Q4 FY 2014 FY 2015 2014 2015 Product Revenue $17.9 $25.6 $75.5 $87.7 Total Revenue $23.3 $30.9 $105.6 $93.0 Net Income $7.8 $11.0 $38.3 $30.8 Diluted EPS $0.51 $0.72 $2.51 $2.01 Dollars in millions, except per-share amounts • Product Revenue Grew 16% in FY 2015 and 43%
Slide 7: Q&A
Q&A Anika Therapeutics, Inc. Fourth Quarter 2015 Earnings Call Presentation February 25, 2016